Ibrance

Palbociclib

7.4 High risk

Ibrance & White blood cell count decreased

16.0%

of users reported White blood cell count decreased

72.8%

also reported Severe reaction

98.8%

are women

Most common medical consequences

Severe reaction
72.8%
Hospitalization
22.0%
Death
4.3%
Disability
0.3%
Life-threatening condition
0.3%
Medical Intervention
0.2%

Have you experienced any negative side effects from this medication?

Ibrance: general information

Most common side effects (602)

Most commonly affected ages

0 - 9 years
<0.1%
10 - 19 years
<0.1%
20 - 29 years
0.1%
30 - 39 years
2.3%
40 - 49 years
7.3%
50 - 59 years
18.8%
60 - 69 years
32.0%
70 - 79 years
27.5%
80 - 89 years
10.7%
90 - 99 years
1.2%